Recently, the team led by Guoqi Li and Bo Xu from the Institute of Automation, Chinese Academy of Sciences, published a ...
Gossamer Bio advances the Feb. 2026 PROSERA Phase 3 readout for seralutinib in PAH, with expanded endpoints and a new ILD trial. Learn why GOSS stock is a hold.
Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...
Converting a Traditional IRA to a Roth isn’t complicated once you’re clear on the taxes you’ll owe, but for anyone 60 or older, the upfront tax hit (and the bigger RMDs you’re trying to avoid) can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results